ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
62,908.93
0.03%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. CVRx Inc (CVRX)

  7. CVRx Inc (CVRX) Noticias

CVRX CVRx Inc

9.22
0.74 (8.73%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
CVRx Inc CVRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.74 8.73% 9.22 17:08:56
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.72 8.53 9.49 9.22 8.48
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:05GLOBECVRx Reports First Quarter 2024 Financial and Operating..
16/4/202415:30GLOBECVRx to Report First Quarter 2024 Financial and Operating..
15/4/202406:30GLOBECVRx announces availability of additional data supporting..
22/2/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:42EDGAR2Form 144 - Report of proposed sale of securities
14/2/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/2/202415:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/2/202415:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/2/202418:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202407:08EDGAR2Form 8-K - Current report
31/1/202407:00GLOBECVRx Announces Appointment of Kevin Hykes as President and..
25/1/202415:11EDGAR2Form 8-K - Current report
25/1/202415:05GLOBECVRx Reports Fourth Quarter and Full Year 2023 Financial and..
19/1/202408:24EDGAR2Form SC 13D/A - General statement of acquisition of..
11/1/202415:30GLOBECVRx to Report Fourth Quarter 2023 Financial and Operating..
08/1/202407:34EDGAR2Form 8-K - Current report
08/1/202407:30GLOBECVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023..
02/1/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202307:03EDGAR2Form SC 13D/A - General statement of acquisition of..
27/12/202315:30GLOBECVRx to Present at the 42nd Annual J.P. Morgan Healthcare..
26/12/202307:13EDGAR2Form 8-K - Current report
26/12/202307:05GLOBECVRx receives FDA approval for expanded labeling of Barostim
18/12/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202315:32EDGAR2Form 8-K - Current report
15/11/202315:21GLOBECVRx to Present at the 35th Annual Piper Sandler Healthcare..
03/11/202307:00GLOBECMS Increases Outpatient Payment for Barostim Procedure
31/10/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202315:23EDGAR2Form 8-K - Current report
26/10/202315:15GLOBECVRx Reports Third Quarter 2023 Financial and Operating..
18/10/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202315:30GLOBECVRx to Report Third Quarter 2023 Financial and Operating..
20/9/202315:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202315:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202317:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202307:30GLOBECVRx to Present at the Canaccord Genuity 43rd Annual Growth..
25/7/202315:20EDGAR2Form 8-K - Current report
25/7/202315:15GLOBECVRx Reports Second Quarter 2023 Financial and Operating..
11/7/202315:30GLOBECVRx to Report Second Quarter 2023 Financial and Operating..
22/6/202315:30GLOBECVRx Set to Join Russell 2000 & 3000 Indexes
25/5/202307:30GLOBECVRx to Present at the William Blair 43rd Annual Growth..

Su Consulta Reciente

NASDAQ
CVRX
CVRx
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados